Effect of a Cooling Sensation Flavor on the Swallow Response in Post-stroke Patients With Oropharyngeal Dysphagia
Launched by HOSPITAL DE MATARÓ · Jan 31, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a special cooling flavor in a drink can help improve swallowing in patients who have difficulty swallowing after a stroke, a condition known as oropharyngeal dysphagia. Researchers want to see if this cooling sensation, combined with a thicker drink, can make swallowing easier and safer for these patients. The trial will involve two groups of 25 participants each, who will try both the cooling flavor and a control drink during two separate visits.
To be eligible for the trial, participants must be at least 18 years old and have had a stroke at least three months prior, resulting in chronic swallowing difficulties. They should be able to safely swallow both the study drink and the control drink. Throughout the trial, participants will undergo various assessments related to their swallowing ability. This study is currently recruiting participants and aims to find a new way to help improve the quality of life for those with swallowing disorders following a stroke.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ≥18 years
- • Patients with chronic OD as a consequence of stroke (more than 3 month since stroke diagnostic)
- • Patients with impaired safety and/or efficacy of swallow (V-VST)
- • Patients that can swallow safely the investigation and control product according to the viscosity of the product and the results of the V-VST
- • Patients able to follow the protocol and give informed consent
- Exclusion Criteria:
- • Pregnancy
- • Life expectancy \<3 months or palliative care
- • OD diagnosis prior to stroke
- • Dementia (GDS 4 or higher)
- • Allergy to the investigation and/or control product or to any of its components
- • Participation in another interventional study in the month prior to inclusion
- • Current users of a pre-thickened ONS drink with cooling sensation flavor
About Hospital De Mataró
Hospital de Mataró is a leading healthcare institution located in Mataró, Spain, dedicated to advancing medical research and improving patient care through clinical trials. As a prominent sponsor of clinical studies, the hospital fosters innovative research initiatives that aim to evaluate new treatments and therapies across various medical fields. With a commitment to ethical standards and patient safety, Hospital de Mataró collaborates with multidisciplinary teams of healthcare professionals and researchers to contribute to the global body of medical knowledge while enhancing the health outcomes of the communities it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Mataró, Barcelona, Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported